NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (“ 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.

Trump credited Musk with significant cuts to the federal workforce and said, "We'll remember you," while promising that more ...

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

Taylor Swift appears to be moving on from her high-profile friendship with Blake Lively and quietly leaning into another.

The New York Times reports that the billionaire experienced some negative effects from frequent drug use while stumping for ...

But the science didn’t stop conspiracists from claiming that the jab was causing more harm than good, spreading ...

Blake Lively's products are reportedly suffering a drop in sales amid her legal dispute with actor Justin Baldoni.

The values of vegetarians diverge sharply from those of meat-eaters, revealing a profile less about kindness and more about ...

HP Inc.'s weak Q2, tariff risks, and high SG&A offset strong personal systems growth and FCF, keeping upside limited. Find ...

On the panel I served on, nobody used the letters “DEI” to justify decisions, though the administration would later claim ...

Explore the history of the internet and its social impact, highlighting key developments and current trends shaping global communication, privacy, and digital inclusion.

Review of the Infinix GT 30 Pro—gaming triggers, high FPS, and wireless cooling make it stand out, but is it worth the price?